SHRSP/A3N |
serum alanine aminotransferase activity level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood alanine transaminase amount |
female |
120 days-140 days |
24 |
84.0 |
U/l |
7.0 |
34.29 |
automated serum analysis |
0.0 |
0 |
107610 |
3093 |
SHRSP/A3N |
serum lactate dehydrogenase activity level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood lactate dehydrogenase amount |
male |
120 days-140 days |
10 |
227.0 |
U/l |
43.0 |
135.98 |
automated serum analysis |
0.0 |
0 |
107613 |
3093 |
SHRSP/A3N |
serum free fatty acids level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood free fatty acid amount |
female |
120 days-140 days |
15 |
796.0 |
mmol/l |
61.0 |
236.25 |
automated serum analysis |
0.0 |
0 |
107619 |
3093 |
SHRSP/A3N |
serum glucose level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood glucose amount |
female |
120 days-140 days |
15 |
194.0 |
mg/dl |
17.0 |
65.84 |
automated serum analysis |
0.0 |
0 |
107631 |
3093 |
SHRSP/A3N |
serum creatine kinase activity level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood creatine kinase amount |
female |
120 days-140 days |
15 |
141.0 |
U/l |
16.0 |
61.97 |
automated serum analysis |
0.0 |
0 |
107603 |
3093 |
SHRSP/A3N |
serum aspartate aminotransferase activity level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood aspartate transaminase amount |
male |
120 days-140 days |
24 |
46.0 |
U/l |
8.0 |
39.19 |
automated serum analysis |
0.0 |
0 |
107604 |
3093 |
SHRSP/A3N |
serum aspartate aminotransferase activity level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood aspartate transaminase amount |
male |
120 days-140 days |
10 |
123.0 |
U/l |
24.0 |
75.89 |
automated serum analysis |
0.0 |
0 |
107605 |
3093 |
SHRSP/A3N |
serum free fatty acids level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood free fatty acid amount |
male |
120 days-140 days |
24 |
180.0 |
mmol/l |
17.0 |
83.28 |
automated serum analysis |
0.0 |
0 |
107616 |
3093 |
SHRSP/A3N |
serum triglyceride level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood triglyceride amount |
male |
120 days-140 days |
10 |
145.0 |
mg/dl |
7.0 |
22.14 |
automated serum analysis |
0.0 |
0 |
107621 |
3093 |
SHRSP/A3N |
serum triglyceride level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood triglyceride amount |
female |
120 days-140 days |
24 |
92.0 |
mg/dl |
7.0 |
34.29 |
automated serum analysis |
0.0 |
0 |
107622 |
3093 |
SHRSP/A3N |
serum urea nitrogen level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood urea nitrogen amount |
female |
120 days-140 days |
15 |
23.0 |
mg/dl |
2.0 |
7.75 |
automated serum analysis |
0.0 |
0 |
107635 |
3093 |
SHRSP/A3N |
serum creatine kinase activity level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood creatine kinase amount |
male |
120 days-140 days |
24 |
120.0 |
U/l |
11.0 |
53.89 |
automated serum analysis |
0.0 |
0 |
107600 |
3093 |
SHRSP/A3N |
serum creatine kinase activity level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood creatine kinase amount |
female |
120 days-140 days |
24 |
111.0 |
U/l |
9.0 |
44.09 |
automated serum analysis |
0.0 |
0 |
107602 |
3093 |
SHRSP/A3N |
serum aspartate aminotransferase activity level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood aspartate transaminase amount |
female |
120 days-140 days |
15 |
166.0 |
U/l |
5.0 |
19.36 |
automated serum analysis |
0.0 |
0 |
107607 |
3093 |
SHRSP/A3N |
serum alanine aminotransferase activity level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood alanine transaminase amount |
male |
120 days-140 days |
24 |
70.0 |
U/l |
6.0 |
29.39 |
automated serum analysis |
0.0 |
0 |
107608 |
3093 |
SHRSP/A3N |
serum alanine aminotransferase activity level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood alanine transaminase amount |
male |
120 days-140 days |
10 |
264.0 |
U/l |
62.0 |
196.06 |
automated serum analysis |
0.0 |
0 |
107609 |
3093 |
SHRSP/A3N |
serum alanine aminotransferase activity level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood alanine transaminase amount |
female |
120 days-140 days |
15 |
285.0 |
U/l |
19.0 |
73.59 |
automated serum analysis |
0.0 |
0 |
107611 |
3093 |
SHRSP/A3N |
serum lactate dehydrogenase activity level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood lactate dehydrogenase amount |
female |
120 days-140 days |
24 |
96.0 |
U/l |
8.0 |
39.19 |
automated serum analysis |
0.0 |
0 |
107614 |
3093 |
SHRSP/A3N |
serum lactate dehydrogenase activity level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood lactate dehydrogenase amount |
female |
120 days-140 days |
15 |
212.0 |
U/l |
12.0 |
46.48 |
automated serum analysis |
0.0 |
0 |
107615 |
3093 |
SHRSP/A3N |
serum free fatty acids level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood free fatty acid amount |
male |
120 days-140 days |
10 |
485.0 |
mmol/l |
42.0 |
132.82 |
automated serum analysis |
0.0 |
0 |
107617 |
3093 |
SHRSP/A3N |
serum triglyceride level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood triglyceride amount |
male |
120 days-140 days |
24 |
97.0 |
mg/dl |
5.0 |
24.49 |
automated serum analysis |
0.0 |
0 |
107620 |
3093 |
SHRSP/A3N |
serum glucose level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood glucose amount |
female |
120 days-140 days |
24 |
145.0 |
mg/dl |
3.0 |
14.7 |
automated serum analysis |
0.0 |
0 |
107630 |
3093 |
SHRSP/A3N |
serum urea nitrogen level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood urea nitrogen amount |
male |
120 days-140 days |
10 |
33.0 |
mg/dl |
6.0 |
18.97 |
automated serum analysis |
0.0 |
0 |
107633 |
3093 |
SHRSP/A3N |
serum urea nitrogen level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood urea nitrogen amount |
female |
120 days-140 days |
24 |
24.0 |
mg/dl |
1.0 |
4.9 |
automated serum analysis |
0.0 |
0 |
107634 |
3093 |
SHRSP/A3N |
serum urea nitrogen level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood urea nitrogen amount |
male |
120 days-140 days |
24 |
19.0 |
mg/dl |
1.0 |
4.9 |
automated serum analysis |
0.0 |
0 |
107632 |
3093 |
SHRSP/A3N |
serum creatine kinase activity level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood creatine kinase amount |
male |
120 days-140 days |
10 |
164.0 |
U/l |
23.0 |
72.73 |
automated serum analysis |
0.0 |
0 |
107601 |
3093 |
SHRSP/A3N |
serum aspartate aminotransferase activity level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood aspartate transaminase amount |
female |
120 days-140 days |
24 |
51.0 |
U/l |
6.0 |
29.39 |
automated serum analysis |
0.0 |
0 |
107606 |
3093 |
SHRSP/A3N |
serum glucose level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood glucose amount |
male |
120 days-140 days |
24 |
146.0 |
mg/dl |
2.0 |
9.8 |
automated serum analysis |
0.0 |
0 |
107628 |
3093 |
SHRSP/A3N |
serum glucose level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood glucose amount |
male |
120 days-140 days |
10 |
223.0 |
mg/dl |
14.0 |
44.27 |
automated serum analysis |
0.0 |
0 |
107629 |
3093 |
SHRSP/A3N |
serum lactate dehydrogenase activity level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood lactate dehydrogenase amount |
male |
120 days-140 days |
24 |
110.0 |
U/l |
12.0 |
58.79 |
automated serum analysis |
0.0 |
0 |
107612 |
3093 |
SHRSP/A3N |
serum triglyceride level |
reproduction condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood triglyceride amount |
female |
120 days-140 days |
15 |
134.0 |
mg/dl |
21.0 |
81.33 |
automated serum analysis |
0.0 |
0 |
107623 |
3093 |
SHRSP/A3N |
serum free fatty acids level |
control condition |
Wexler BC, Stroke. 1980 Nov-Dec;11(6):665-71. doi: 10.1161/01.str.11.6.665. |
blood free fatty acid amount |
female |
120 days-140 days |
24 |
180.0 |
mmol/l |
16.0 |
78.38 |
automated serum analysis |
0.0 |
0 |
107618 |
3093 |